PYC Therapeutics Ltd banner

PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 1.415 AUD -2.75% Market Closed
Market Cap: AU$1.3B

Wall Street
Price Targets

PYC Price Targets Summary
PYC Therapeutics Ltd

Wall Street analysts forecast PYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PYC is 3.627 AUD with a low forecast of 2.269 AUD and a high forecast of 5.209 AUD.

Lowest
Price Target
2.269 AUD
60% Upside
Average
Price Target
3.627 AUD
156% Upside
Highest
Price Target
5.209 AUD
268% Upside
PYC Therapeutics Ltd Competitors:
Price Targets
HCAT
Health Catalyst Inc
199% Upside
VNOM
Viper Energy Partners LP
17% Upside
PWP
Perella Weinberg Partners
62% Upside

Revenue
Forecast

22% / Year
Past Growth
66% / Year
Estimated Growth
Estimates Accuracy
-47%
Average Miss
22% / Year
Past Growth
66% / Year
Estimated Growth
Estimates Accuracy
-47%
Average Miss

For the last 13 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 22%. The projected CAGR for the next 3 years is 66%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PYC's stock price target?
Price Target
3.627 AUD

According to Wall Street analysts, the average 1-year price target for PYC is 3.627 AUD with a low forecast of 2.269 AUD and a high forecast of 5.209 AUD.

What is PYC Therapeutics Ltd's Revenue forecast?
Projected CAGR
66%

For the last 13 years the compound annual growth rate for PYC Therapeutics Ltd's revenue is 22%. The projected CAGR for the next 3 years is 66%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett